Table 1 Clinical Characteristics of Cohorts Study Groups.
Discovery Cohort | Clinical Groups [Total N = 545] | |||
---|---|---|---|---|
UM | CM | SMA | CC | |
N (%) | 216 (40) | 69 (12) | 86 (16) | 174 (32) |
Age (months) Median (IQR) | 42 (24–78) | 45 (29–60) | 29 (20–44) | 84 (60–120) |
Sex: F/M | 88/128 | 40/29 | 39/47 | 95/79 |
PCV (%) Median (IQR) | 29 (24–34) | 27 (21–31) | 13 (11–15) | 35 (33–37) |
Parasite Density Median (IQR) | 29940 (2464–52021) | 10428 (1280–58844) | 21883 (1222–47847) | N/A |
Validation Cohort | Clinical Groups [Total N = 166] | |||
UM | CM | SMA | CC | |
N (%) | 71 (40) | 40 (21) | 36 (19) | 19 (10) |
Age (months) Median (IQR) | 36 (21–73) | 47 (36–62) | 39 (27–61) | 48 (32–72) |
Sex: F/M | 27/44 | 17/23 | 8/28 | 8/11 |
PCV (%) PD0 Median (IQR) | 32 (27–35) | 25 (23–30) | 13 (11–15) | 34 (32–35) |
PCV (%) PD28 Median (IQR) | 35 (29–40) | 34 (27–40) | 34 (27–37) | 35 (27–40) |
Parasite Density Median (IQR) | 27429 (1901–54680) | 5590 (1314–81923) | 32131 (2487–103822) | N/A |
HTS Cohort | Clinical Groups [Total N = 401] | |||
UM | CM | SMA | CC | |
N (%) | 153 (38) | 66 (16) | 81 (20) | 101(26) |
Age (months) Median (IQR) | 38 (21–71) | 43 (28–60) | 29 (22–45) | 80(48–96) |
Sex: F/M | 73/80 | 31/35 | 39/42 | 58/43 |
PCV (%) Median (IQR) | 31 (24–35) | 26 (21–31) | 14 (11–15) | 35 (33–36) |
Parasite Density Median (IQR) | 27717 (2431–53333) | 20099 (1280–55688) | 16089 (1093–47221) | N/A |